Paradoxical activation of oncogenic signaling as a cancer treatment strategy (2024)
Source: Cancer Discovery. Unidade: IQ
Subjects: ONCOGENES, NEOPLASIAS
ABNT
DIAS, Matheus Henrique et al. Paradoxical activation of oncogenic signaling as a cancer treatment strategy. Cancer Discovery, v. 14, n. 7, p. 1276–1301, 2024Tradução . . Disponível em: https://dx.doi.org/10.1158/2159-8290.CD-23-0216. Acesso em: 18 nov. 2024.APA
Dias, M. H., Friskes, A., Wang, S., Fernandes Neto, J. M., Gemert, F. van, Mourragui, S., et al. (2024). Paradoxical activation of oncogenic signaling as a cancer treatment strategy. Cancer Discovery, 14( 7), 1276–1301. doi:10.1158/2159-8290.CD-23-0216NLM
Dias MH, Friskes A, Wang S, Fernandes Neto JM, Gemert F van, Mourragui S, Papagianni C, Kuiken HJ, Mainardi S, Villanueva DA, Lieftink C, Morris B, Dekker A, Dijk E van, Wilms LHS, Jansen RA, Sánchez AM, Malzer E, Vidal A, Santos C, Silva MS da. Paradoxical activation of oncogenic signaling as a cancer treatment strategy [Internet]. Cancer Discovery. 2024 ; 14( 7): 1276–1301.[citado 2024 nov. 18 ] Available from: https://dx.doi.org/10.1158/2159-8290.CD-23-0216Vancouver
Dias MH, Friskes A, Wang S, Fernandes Neto JM, Gemert F van, Mourragui S, Papagianni C, Kuiken HJ, Mainardi S, Villanueva DA, Lieftink C, Morris B, Dekker A, Dijk E van, Wilms LHS, Jansen RA, Sánchez AM, Malzer E, Vidal A, Santos C, Silva MS da. Paradoxical activation of oncogenic signaling as a cancer treatment strategy [Internet]. Cancer Discovery. 2024 ; 14( 7): 1276–1301.[citado 2024 nov. 18 ] Available from: https://dx.doi.org/10.1158/2159-8290.CD-23-0216